I am still a bit bemused by the wording of the announcement.
”FDA has informed the company that following additional consideration the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission”
Note - not “data”, not “new information”, but “consideration”.
Were the FDA head honchos having a round of golf, and decided amongst themselves that they had been a bit hard on the Aussie battler? Then back to the clubhouse for a scotch or three.
Or perhaps Big Pharma have “advised” the FDA top order that Meso's gonads have been squeezed enough, so give them a win that also allows BP to make a cheap TO?
Don't get me wrong. My wife is very happy to see the reverse in fortunes, and so quick after that dilutive capital raise too!
- Forums
- ASX - By Stock
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
I am still a bit bemused by the wording of the announcement....
-
-
- There are more pages in this discussion • 646 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.12 |
Change
0.013(1.13%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.13 | $1.16 | $1.11 | $2.346M | 2.077M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 14312 | $1.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.12 | 45824 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 128852 | 1.120 |
10 | 100947 | 1.115 |
18 | 122356 | 1.110 |
12 | 803941 | 1.105 |
19 | 165865 | 1.100 |
Price($) | Vol. | No. |
---|---|---|
1.125 | 40165 | 12 |
1.130 | 28879 | 12 |
1.135 | 20977 | 9 |
1.140 | 35331 | 9 |
1.145 | 57041 | 7 |
Last trade - 10.36am 08/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |